Literature DB >> 7144218

Surgical treatment of pleural mesothelioma.

P M McCormack, F Nagasaki, B S Hilaris, N Martini.   

Abstract

From 1939 through 1981, 170 patients were seen and treated for pleural mesothelioma. Twenty-one tumors were benign, 47 were fibrosarcomatous, and 102 were epithelioma. Resection was the main mode of treatment in benign and fibrosarcomatous mesothelioma. Treatment of diffuse epithelial mesothelioma presented the greatest challenge. Surgical therapy, radiation therapy, and chemotherapy were used in combination in these patients. The review of our patients treated prior to 1972 had shown no benefit from including pulmonary resection in the surgical treatment of these tumors. Since then, all patients with diffuse mesothelioma were treated by pleurectomy without pulmonary resection. Both internal and external radiation therapy were also used to enhance local control. Forty-nine percent of patients with epithelial mesothelioma lived 1 year. The median survival in patients whose disease was controlled by these methods was 21 months. Despite the poor prognosis in malignant mesothelioma, better controlled by these methods was 21 months. Despite the poor prognosis in malignant mesothelioma, better survival was achieved when the treatment included operation combined with radiation and chemotherapy.

Entities:  

Mesh:

Year:  1982        PMID: 7144218

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Recurrent malignant pleural mesothelioma: case report.

Authors:  D A Cooley; O H Frazier
Journal:  Tex Heart Inst J       Date:  1983-03

2.  Current therapies for malignant pleural mesothelioma.

Authors:  Takashi Nakano
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

3.  Laparoscopy: an important tool in the staging of malignant pleural mesothelioma.

Authors:  K C Conlon; V W Rusch; S Gillern
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

4.  Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.

Authors:  Andrea Bille; Elizabeth Belcher; Hilgard Raubenheimer; David Landau; Paul Cane; James Spicer; Loïc Lang-Lazdunski
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

5.  The influence of the diagnostic technique on the histopathological diagnosis in malignant mesothelioma.

Authors:  T van Gelder; H C Hoogsteden; J P Vandenbroucke; T H van der Kwast; H T Planteydt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

6.  Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.

Authors:  D J Sugarbaker; J P Garcia; W G Richards; D H Harpole; E Healy-Baldini; M M DeCamp; S J Mentzer; M J Liptay; G M Strauss; S J Swanson
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

7.  Menogaril in the treatment of malignant mesothelioma: a phase II study.

Authors:  C A Hudis; D P Kelsen
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

Review 8.  Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival.

Authors:  E J Mark; D H Shin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 9.  Cerebral metastases in pleural mesothelioma: case report and review of the literature.

Authors:  M Wroński; M Burt
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

10.  Malignant pleural mesothelioma in western Glasgow 1980-6.

Authors:  G Hulks; J S Thomas; E Waclawski
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.